SNSE
SenseiยทNASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
SNSE Profile
Sensei Biotherapeutics, Inc.
An immuno-oncology company focused on the therapeutics for cancer
Biological Technology
12/01/2017
02/04/2021
NASDAQ Stock Exchange
14
12-31
Common stock
1405 Research Blvd, Suite 125, Rockville, MD 20850
--
Sensei Biotherapeutics, Inc., a clinical-stage immunotherapy company, was incorporated in Delaware on December 1, 2017. The company is an immuno-oncology company focused on the discovery and development of next-generation therapies for cancer patients. Through the TMAb (Tumor Microenvironment Activating Biologics) platform, the Company is developing highly selective therapies designed to selectively disable immunosuppressive signals or activate immune stimulating signals in the tumor microenvironment to release T cells against tumors.
